Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia

Journal of Paediatrics and Child Health

Volumn 40, Issue 7, 2004, Pages 356-359

  Kent, A ^a,b   Dahlstrom, J E ^a,b  

^a CANBERRA HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antenatal steroids; Bronchopulmonary dysplasia; Chorioamnionitis; Placenta; Preterm infants

Indexed keywords

LUNG SURFACTANT; OXYGEN; STEROID;

ARTICLE; BIRTH WEIGHT; CHORIOAMNIONITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DEATH; DELIVERY; DISEASE ASSOCIATION; DRUG USE; FEMALE; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; INFANT; INFLAMMATION; INTRAUTERINE INFECTION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; POSITIVE END EXPIRATORY PRESSURE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RESPIRATORY FAILURE;

BETAMETHASONE; BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; DATABASES, FACTUAL; DEXAMETHASONE; FEMALE; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LOGISTIC MODELS; MALE; OXYGEN; PLACENTA; PREGNANCY; PROSPECTIVE STUDIES;

EID: 3142774736     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2004.00366.x     Document Type: Article

References (27)

1. Mueller-Heubach E, Rubinstein DN, Schwarz SS. Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet. Gynecol. 1990; 75: 622-6.
2. Russell P. Inflammatory lesions of the human placenta. I. Clinical significance of acute chorioamnionitis. Am. J. Diagn. Gynecol. Obstet. 1979; 1: 127-37.
3. Chellam VG, Rushton DI. Chorioamnionitis and funiculitis in the placentas of 200 births weighing less than 2.5 kg. Br. J. Obstet. Gynaecol. 1985; 92: 808-14.
4. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-15.
5. Fujimura M, Takeuchi T, Kitajima H, Nakayama M. Chorioamnionitis and serum Ig M in Wilson-Mikity syndrome. Arch. Dis. Child 1989; 64: 1379-83.
6. Matsuda T, Nakajima T, Hattori S et al. Necrotizing funisitis: Clinical significance and association with chronic lung disease in premature infants. Am. J. Obstet. Gynecol. 1997; 177: 1402-7.
7. Redline RW, Wilson-Costello D, Hack M. Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr. Res. 2002; 52: 713-19.
8. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline membrane disease. Bronchopulmonary dysplasia. N. Engl. J. Med. 1967; 276: 357-68.
9. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am. J. Respir. Crit. Care Med. 1999; 160: 1333-46.
10. Husain AN, Siddiqui NH, Stocker IT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum. Pathol. 1998; 29: 710-17.
11. Bry K, Lappalainen U, Hallman M. Intra-amniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J. Clin. Invest. 1997; 99: 2992-9.
12. Jobe AH, Newnham JP, Willet KE et al. Effects of antenatal endotoxin and glucocorticoids on the lungs of preterm lambs. Am. J. Obstet. Gynecol. 2000; 182: 401-8.
13. Willet K, Jobe A, Ikegami M, Brennan S, Newnham J, Sly P. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr. Res. 2000; 48: 782-8.
14. Moss TJ, Newnham JP, Willett KE, Kramer BW, Jobe AH, Ikegami M. Early gestational intra-amniotic endotoxin: lung function, surfactant, and morphometry. Am. J. Respir. Crit. Care Med. 2002; 165: 805-11.
15. Elimian A, Verma U, Beneck D, Cipriano R, Visintainer P, Tejani N. Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes. Obstet. Gynecol. 2000; 96: 333-6.
16. Vermillion ST, Soper DE, Bland ML, Newman RB. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes. Am. J. Obstet. Gynecol. 2000; 183: 925-9.
17. Kosuge S, Ohkuchi A, Minakami H et al. Influence of chorioamnionitis on survival and morbidity in singletons live-born at <32 weeks of gestation. Acta Obstet. Gynecol. Scand. 2000; 79: 861-5.
18. Agarwal R, Chiswick ML, Rimmer S et al. Antenatal steroids are associated with a reduction in the incidence of cerebral white matter lesions in the very low birth weight infants. Arch. Dis. Child Fetal Neon. Ed. 2002; 86: F96-101.
19. Costeloe K, Hennessey E, Gibson AT, Marlow N, Wilkinson AR. The EPICure Study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000; 106: 659-71.
20. Van Marter LJ, Dammann O, Allred EN et al. (Developmental Epidemiology Network Investigators). Chorioamnionitis, mechanical ventilation, and postnatal septic modulators of chronic lung disease. J. Pediatr. 2002; 140: 171-6.
21. Naeye RL. Functionally important disorders of the placenta, umbilical cord, and fetal membranes. Hum. Pathol. 1987; 18: 680-91.
22. Lewis SH, Perrin E. Pathology of the placenta, 2nd edn. Edinburgh: Churchill Livingstone, 1999.
23. Bancalari E. Neonatal Chronic Lung Disease. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine Diseases of the Fetus and Infant, 7th edn. St Louis: Mosby, Harcourt Publishers Limited, 2002; 1057-70.
24. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir. Res. 2001; 2: 27-32.
25. Yoon BH, Romero R, Kim KS et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am. J. Obstet. Gynecol 1999; 181: 773-9.
26. Weller I, Roitt I, Brostoff J, Male D. Immunology, 6th edn. Edinburgh: Mosby, Harcourt Publishers Limited, 2001; 313-22.
27. Schmidt B, Cao L, Mackensen-Haen S, Kendziorra H, Klingel K, Speer CP. Chorioamnionitis and inflammation of the fetal lung. Am. J. Obstet. Gynecol. 2001; 184: 173-7.